Latest quarterly snapshot

Fortrea Holdings (FTRE) has put fresh numbers on the table for Q1 2026, with recent quarters showing revenue around US$660.5 million in Q4 2025 and a basic EPS loss of US$0.35 as the company continues to operate in the red. Over the past few reported periods, revenue has moved in a tight band between US$651.3 million and US$710.3 million. Quarterly basic EPS has ranged from a loss of US$0.17 to a much deeper loss of US$6.25, underscoring pressure on margins even as the top line holds around the mid US$600 million mark. For investors, the story this quarter is less about sales volume and more about how much of that revenue is slipping through the cracks in the form of ongoing losses.

See our full analysis for Fortrea Holdings.

With the headline figures in place, the next step is to see how these results stack up against the widely discussed narratives around Fortrea's valuation, growth prospects, and risk profile.

Losses nearing US$1b on US$2.7b revenue

• On a trailing 12 month basis to Q4 2025, Fortrea generated about US$2.7b in revenue but recorded a net loss of roughly US$986.2 million, with basic EPS at a loss of US$10.81 over that period.
• Consensus narrative links this combination of steady revenue and large losses to both opportunity and risk, as:
  • Analysts see long term growth drivers like aging populations and higher R&D spend supporting demand for clinical trials. This fits with revenue holding around US$2.7b over multiple trailing snapshots.
  • At the same time, customer concentration and reliance on third parties mean these losses could remain a feature if cost savings and digital tools do not meaningfully change the economics captured in the trailing 12 month loss of US$986.2 million.

P/S at 0.5x vs industry 3.4x

• With the share price at US$14.53 and Fortrea trading on a P/S of 0.5x compared with 3.4x for the US Life Sciences industry and 10.8x for peers, the stock is also sitting below a DCF fair value of US$23.10 and the analyst price target of US$13.21.
• Bulls argue this discount reflects underappreciated margin potential, yet the current figures set a high bar, because:
  • The business is still loss making over the last 12 months, with net income excluding extra items at a loss of US$986.2 million. Any margin catch up would therefore require a large swing from the current position.
  • Revenue is forecast around 4% growth per year compared with 11.2% for the wider US market. This means the low P/S multiple and gap to the DCF fair value of US$23.10 are being weighed against slower expected top line growth.

Bulls who want to see how the optimistic case is built out in detail around cost savings and digital tools can dig into the full narrative here 🐂 Fortrea Holdings Bull Case

Forecast unprofitable despite 4% growth

• Across the last six reported quarters, quarterly revenue sat between US$651.3 million and US$710.3 million while basic EPS stayed in loss territory, and forecasts still see the company unprofitable over the next three years even with about 4% annual revenue growth versus 11.2% for the US market.
• Bears point to this pattern as a warning sign, and the trailing figures give them some backing, because:
  • Losses widened over the last five years, with historical data showing losses increasing at a very large annualized rate, and the latest trailing 12 month basic EPS loss of US$10.81 suggests profitability is still some distance away.
  • The share price has been more volatile than the US market over the past three months, which fits the bearish concern that the market is reacting sharply to any change in the outlook for revenue growth or the path toward smaller losses.

If you want to see how skeptics connect these loss trends and volatility to their cautious long term view on the stock, check out the detailed bearish case 🐻 Fortrea Holdings Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Fortrea Holdings on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With both bullish and bearish perspectives presented, this is a good moment to review the data yourself and decide where you stand, starting with these 2 key rewards and 2 important warning signs

See What Else Is Out There

Fortrea is still reporting sizeable losses on about US$2.7b in revenue, with a basic EPS loss of US$10.81 and forecasts pointing to continued unprofitability.

If this mix of ongoing losses and share price volatility feels uncomfortable, you can quickly shift your focus toward companies with steadier profiles using the 72 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.